Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

205
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
205
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

262
The pathophysiology of pneumonia involves the following steps:
262
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

230
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
230
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

4.2K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
4.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
  1. Home
  3. Bacterial And Fungal Secondary Infections Occurring In Covid-19 Patients Followed In Intensive Care: A Retrospective Study.
  1. Home
  3. Bacterial And Fungal Secondary Infections Occurring In Covid-19 Patients Followed In Intensive Care: A Retrospective Study.

Related Experiment Video

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.0K

Bacterial and fungal secondary infections occurring in COVID-19 patients followed in intensive care: a retrospective

Erhan Ozyurt1, Aylin Erman Daloglu2, Kerem Inanoglu1

  • 1Department of Anesthesiology and Reanimation, Antalya Training and Research Hospital, University of Health Sciences, Antalya, Turkey.

Journal of Infection in Developing Countries
|April 18, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

Secondary bacterial and fungal infections significantly increased mortality and intensive care unit (ICU) length of stay in COVID-19 patients. Gram-negative pathogens, especially in respiratory infections, were most common, leading to worse outcomes.

Keywords:
COVID-19intensive caresecondary infection

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

522
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

5.4K

Related Experiment Videos

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.0K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

522
An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract
07:42

An Ex vivo Assay to Study Candida albicans Hyphal Morphogenesis in the Gastrointestinal Tract

Published on: July 1, 2020

5.4K

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Virology

Background:

  • Coronavirus disease 2019 (COVID-19) patients admitted to the intensive care unit (ICU) are susceptible to secondary bacterial and fungal infections.
  • Understanding the impact of these secondary infections on patient outcomes is crucial for improving care.

Purpose of the Study:

  • To investigate the effects of secondary bacterial and fungal infections on patient outcomes in COVID-19 patients managed in the ICU.
  • To identify common pathogens and their impact on length of stay and mortality.

Main Methods:

  • Retrospective analysis of 251 reverse transcriptase polymerase chain reaction (RT-PCR) positive COVID-19 patients admitted to the ICU between March 2020 and June 2021.
  • Data collected included demographics, secondary infection pathogens, onset time, and patient outcomes.
  • Cultures from blood, urine, respiratory tract, and catheters were examined.

    • Main Results:

    • Over half of patients (51.4%) developed at least one secondary infection, with respiratory tract infections being most common (41.4%).
    • Gram-negative bacteria were the predominant pathogens (58.4%), and Candida spp. were frequent in urine cultures.
    • Patients with secondary infections experienced significantly longer ICU length of stay (LOS) and higher mortality rates (p < 0.001).

    Conclusions:

    • Secondary infections, particularly Gram-negative bacterial infections in the respiratory tract, are a significant complication in ICU-managed COVID-19 patients.
    • These infections are associated with prolonged ICU stays and increased mortality.
    • Effective management strategies for secondary infections are critical for improving COVID-19 patient outcomes.